Literature DB >> 1319114

Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels.

L Tiret1, B Rigat, S Visvikis, C Breda, P Corvol, F Cambien, F Soubrier.   

Abstract

The hypothesis of a genetic control of plasma angiotensin I-converting enzyme (ACE) level has been suggested both by segregation analysis and by the identification of an insertion/deletion (I/D) polymorphism of the ACE gene, a polymorphism contributing much to the variability of ACE level. To elucidate whether the I/D polymorphism was directly involved in the genetic regulation, plasma ACE activity and genotype for the I/D polymorphism were both measured in a sample of 98 healthy nuclear families. The pattern of familial correlations of ACE level was compatible with a zero correlation between spouses and equal parent-offspring and sib-sib correlations (.24 +/- .04). A segregation analysis indicated that this familial resemblance could be entirely explained by the transmission of a codominant major gene. The I/D polymorphism was associated with marked differences of ACE levels, although these differences were less pronounced than those observed in the segregation analysis. After adjustment for the polymorphism effects, the residual heritability (.280 +/- .096) was significant. Finally, a combined segregation and linkage analysis provided evidence that the major-gene effect was due to a variant of the ACE gene, in strong linkage disequilibrium with the I/D polymorphism. The marker allele I appeared always associated with the major-gene allele s characterized by lower ACE levels. The frequency of allele I was .431 +/- .025, and that of major allele s was .557 +/- .041. The major gene had codominant effects equal to 1.3 residual SDs and accounted for 44% of the total variability of ACE level, as compared with 28% for the I/D polymorphism.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1319114      PMCID: PMC1682892     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  19 in total

1.  Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis.

Authors:  J Lieberman
Journal:  Am J Med       Date:  1975-09       Impact factor: 4.965

2.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

3.  Combined linkage and segregation analysis using regressive models.

Authors:  G E Bonney; G M Lathrop; J M Lalouel
Journal:  Am J Hum Genet       Date:  1988-07       Impact factor: 11.025

4.  The use of measured genotype information in the analysis of quantitative phenotypes in man. I. Models and analytical methods.

Authors:  E Boerwinkle; R Chakraborty; C F Sing
Journal:  Ann Hum Genet       Date:  1986-05       Impact factor: 1.670

5.  A multivariate analysis of family data.

Authors:  A Donner; J J Koval
Journal:  Am J Epidemiol       Date:  1981-07       Impact factor: 4.897

6.  Automated kinetic assay of angiotensin-converting enzyme in serum.

Authors:  B Beneteau; B Baudin; G Morgant; J Giboudeau; F C Baumann
Journal:  Clin Chem       Date:  1986-05       Impact factor: 8.327

7.  Expression and characterization of recombinant human angiotensin I-converting enzyme. Evidence for a C-terminal transmembrane anchor and for a proteolytic processing of the secreted recombinant and plasma enzymes.

Authors:  L Wei; F Alhenc-Gelas; F Soubrier; A Michaud; P Corvol; E Clauser
Journal:  J Biol Chem       Date:  1991-03-25       Impact factor: 5.157

8.  Distribution of plasma angiotensin I-converting enzyme levels in healthy men: relationship to environmental and hormonal parameters.

Authors:  F Alhenc-Gelas; J Richard; D Courbon; J M Warnet; P Corvol
Journal:  J Lab Clin Med       Date:  1991-01

9.  Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat.

Authors:  H J Jacob; K Lindpaintner; S E Lincoln; K Kusumi; R K Bunker; Y P Mao; D Ganten; V J Dzau; E S Lander
Journal:  Cell       Date:  1991-10-04       Impact factor: 41.582

10.  An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.

Authors:  B Rigat; C Hubert; F Alhenc-Gelas; F Cambien; P Corvol; F Soubrier
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

View more
  205 in total

Review 1.  Angiotensin I-converting enzyme: genotype and disease associations.

Authors:  D Crisan; J Carr
Journal:  J Mol Diagn       Date:  2000-08       Impact factor: 5.568

2.  Association of DD genotype of angiotensin-converting enzyme gene (I/D) polymorphism with hypertension among a North Indian population.

Authors:  Garima Rana; Suniti Yadav; Shipra Joshi; K N Saraswathy
Journal:  J Community Genet       Date:  2017-08-02

3.  Association of angiotensin converting enzyme and angiotensin II type 1 receptor genotypes with left ventricular function and mass in patients with angiographically normal coronary arteries.

Authors:  M Hamon; C Amant; C Bauters; F Richard; N Helbecque; E McFadden; J M Lablanche; M Bertrand; P Amouyel
Journal:  Heart       Date:  1997-06       Impact factor: 5.994

4.  Increased amount of the angiotensin-converting enzyme (ACE) mRNA originating from the ACE allele with deletion.

Authors:  Tadashi Suehiro; Tatsuhito Morita; Mari Inoue; Yoshitaka Kumon; Yukio Ikeda; Kozo Hashimoto
Journal:  Hum Genet       Date:  2004-05-26       Impact factor: 4.132

Review 5.  Drug-gene interactions between genetic polymorphisms and antihypertensive therapy.

Authors:  Hedi Schelleman; Bruno H Ch Stricker; Anthonius De Boer; Abraham A Kroon; Monique W M Verschuren; Cornelia M Van Duijn; Bruce M Psaty; Olaf H Klungel
Journal:  Drugs       Date:  2004       Impact factor: 9.546

6.  Genotypes and allele frequencies of angiotensin-converting enzyme (ACE) insertion/deletion polymorphism among Bahraini population with type 2 diabetes mellitus and related diseases.

Authors:  Einas M Al-Harbi; Eman M Farid; Khalid A Gumaa; Jaipaul Singh
Journal:  Mol Cell Biochem       Date:  2011-11-13       Impact factor: 3.396

7.  Epistatic interaction between variations in the angiotensin I converting enzyme and angiotensin II type 1 receptor genes in relation to extent of coronary atherosclerosis.

Authors:  S Ye; S Dhillon; R Seear; L Dunleavey; L B Day; W Bannister; I N M Day; I Simpson
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

8.  The serum angiotensin-converting enzyme and angiotensin II response to altered posture and acute exercise, and the influence of ACE genotype.

Authors:  David Woods; Julie Sanders; Alun Jones; Emma Hawe; Peter Gohlke; Steve E Humphries; John Payne; Hugh Montgomery
Journal:  Eur J Appl Physiol       Date:  2003-11-01       Impact factor: 3.078

9.  Population genetics of the angiotensin-converting enzyme in Chinese.

Authors:  E J Lee
Journal:  Br J Clin Pharmacol       Date:  1994-02       Impact factor: 4.335

10.  Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy.

Authors:  H Yoshida; T Mitarai; T Kawamura; T Kitajima; Y Miyazaki; R Nagasawa; Y Kawaguchi; H Kubo; I Ichikawa; O Sakai
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.